Research ArticleArticle
Histone H3 Lysine 4 Trimethylation, Lysine 27 Trimethylation, and Lysine 27 Acetylation Contribute to the Transcriptional Repression of Solute Carrier Family 47 Member 2 in Renal Cell Carcinoma
Qinqin Yu, Yanqing Liu, Xiaoli Zheng, Qianying Zhu, Zhuowei Shen, Hua Wang, Huadong He, Nengming Lin, Huidi Jiang, Lushan Yu and Su Zeng
Drug Metabolism and Disposition January 2017, 45 (1) 109-117; DOI: https://doi.org/10.1124/dmd.116.073734
Qinqin Yu
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
Yanqing Liu
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
Xiaoli Zheng
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
Qianying Zhu
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
Zhuowei Shen
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
Hua Wang
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
Huadong He
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
Nengming Lin
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
Huidi Jiang
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
Lushan Yu
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
Su Zeng
Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China (Q.Y., Y.L., X.Z., Q.Z., Z.S., H.J., L.Y., S.Z.); Department of Urology, Cancer Hospital of Zhejiang Province, Hangzhou, China (H.W.); and Department of Urology, Hangzhou First People’s Hospital, Hangzhou, China (H.H., N.L.)
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Histone Modification Regulates SLC47A2 Transcription
Qinqin Yu, Yanqing Liu, Xiaoli Zheng, Qianying Zhu, Zhuowei Shen, Hua Wang, Huadong He, Nengming Lin, Huidi Jiang, Lushan Yu and Su Zeng
Drug Metabolism and Disposition January 1, 2017, 45 (1) 109-117; DOI: https://doi.org/10.1124/dmd.116.073734
Research ArticleArticle
Histone Modification Regulates SLC47A2 Transcription
Qinqin Yu, Yanqing Liu, Xiaoli Zheng, Qianying Zhu, Zhuowei Shen, Hua Wang, Huadong He, Nengming Lin, Huidi Jiang, Lushan Yu and Su Zeng
Drug Metabolism and Disposition January 1, 2017, 45 (1) 109-117; DOI: https://doi.org/10.1124/dmd.116.073734
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement